Shailesh Bobby Jain, MD, MPH, MEHP, ABDA

  • 4Articles
  • 70.5KReads
  • 2020–2023Active
  • 19Collaborators
  • 49Citations

About

Shailesh Bobby Jain, MD, MPH, MEHP, ABDA, is affiliated with Texas Tech University Health Sciences Center at Permian Basin in Midland. Jain has published extensively on topics including autism spectrum disorders, child and adolescent psychiatry, COVID-19 related psychosis, and major depressive disorder. The work covers psychiatric comorbidities in adolescents with autism, psychiatric disorders in children in welfare custody, and antidepressant medication strategies. Jain's research has appeared in Psychiatrist.com from 2020 to 2023.

Publications

PCC
Psychiatric Disorders Among Child Welfare Custody Patients
Original Research

Psychiatric Disorders Among Child Welfare Custody Patients

November 21, 2023

Children and adolescents in the child welfare system are associated with a higher risk of mental health problems. Factors that can prevent psychiatric comorbidities in the child welfare population...
, , , et al
PCC
New-Onset Psychosis Secondary to COVID-19 Infection
Brief Report

New-Onset Psychosis Secondary to COVID-19 Infection

July 13, 2023

Neuropsychiatric complications can develop within weeks of COVID-19 infection and thus should be considered a causative agent of sudden and new-onset psychotic disorders.
, , , et al
PCC
Sex Differences in Psychiatric Comorbidities Among Adolescents With Autism
Original Research

Sex Differences in Psychiatric Comorbidities Among Adolescents With Autism

September 27, 2022

The objective of this article was to investigate sex differences in psychiatric comorbidities in adolescents with autism spectrum disorder.
, , , et al
JCP
Original Research

Switching Antidepressants Following SSRI Failure

August 11, 2020

An antidepressant medication switch often follows a failed initial trial with SSRIs. This study sought to determine the probability and timing of both response and remission and the optimal...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe